Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Nuvation Bio Inc. (NUVB)

Compare
1.6600
0.0000
(0.00%)
At close: April 4 at 4:00:02 PM EDT
1.6780
+0.02
+(1.08%)
After hours: April 4 at 7:42:42 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 5.71M
Earnings -49.45M

Q1'24

Q2'24

Q3'24

Q4'24

-400M
-300M
-200M
-100M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

5.00
8.20 Average
1.6600 Current
10.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate -0.12-0.13-0.57-0.67
Low Estimate -0.13-0.14-0.63-0.74
High Estimate -0.11-0.12-0.51-0.59
Year Ago EPS -0.04-1.85-1.99-0.57

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6665
Avg. Estimate 416.67k416.67k13.56M73.23M
Low Estimate ----5.5M25M
High Estimate 2.5M2.5M20.35M122.25M
Year Ago Sales --1.44M7.87M13.56M
Sales Growth (year/est) 0.00%-70.96%72.24%440.05%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.05-0.05-0.1-0.12
EPS Actual -0.04-1.85-0.12-0.12
Difference 0.01-1.8-0.020
Surprise % 11.00%-3,601.28%-23.30%2.92%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.12-0.13-0.57-0.67
7 Days Ago -0.13-0.13-0.55-0.51
30 Days Ago 00-0.51-0.44
60 Days Ago 00-0.51-0.44
90 Days Ago 00-0.52-0.49

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 111--
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
NUVB -169.66%92.98%71.40%-16.67%
S&P 500 6.57%6.54%9.73%14.28%

Upgrades & Downgrades

Initiated Jones Trading: Buy 3/12/2025
Maintains HC Wainwright & Co.: Buy to Buy 3/10/2025
Maintains HC Wainwright & Co.: Buy to Buy 1/23/2025
Maintains HC Wainwright & Co.: Buy to Buy 1/22/2025
Reiterates RBC Capital: Outperform to Outperform 1/7/2025
Reiterates HC Wainwright & Co.: Buy to Buy 1/6/2025

Related Tickers